Meeting An Aggressive Go-To-Clinic Timeline

Finding an outsourcing partner capable of giving your company proper attention and meeting project milestones on schedule is crucial to ensure patients in need receive treatment in a timely manner. A mid-sized pharma company was working with a very large CDMO to enter clinical trials for a potentially life-changing medication that may slow the progression of common neurodegenerative disorders. However, the CDMO’s inability to devote the resources necessary to meet the company’s aggressive go-to-clinic timelines delayed production of the clinical trial batches for months.

This delay from their CDMO jeopardized their market commitments for the start of Phase 2 and 3 clinical trials. Examine how Adare’s expertise, preparation, and resources provided the company’s clinical trials with the supplies needed to be conducted successfully and led to a successful partnership for the company’s clinical trials moving forward.